Coping Together After Breast Cancer
Addressing Sexual Concerns in Breast Cancer Survivors: Randomized Controlled Trial of a Novel Couple-Based Intervention
2 other identifiers
interventional
240
1 country
1
Brief Summary
The objective of the proposed study is to evaluate an Intimacy Enhancement (IE) intervention in 120 female early stage breast cancer survivors reporting sexual concerns and their intimate partners (240 total participants). Couples will be randomized 1:1 to receive either the IE intervention or to an information and support condition (Living Healthy Together). The investigators will evaluate intervention effects on patient and partner sexual, relationship, and psychological outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable breast-cancer
Started May 2019
Typical duration for not_applicable breast-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 24, 2019
CompletedFirst Posted
Study publicly available on registry
April 29, 2019
CompletedStudy Start
First participant enrolled
May 24, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 14, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
April 14, 2023
CompletedResults Posted
Study results publicly available
July 11, 2024
CompletedJuly 11, 2024
June 1, 2024
3.9 years
April 24, 2019
May 16, 2024
June 17, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Change in Self-Reported Patient Sexual Function
Patients' self-reported sexual function will be measured using the 19-item Female Sexual Function Index (FSFI).Total scale scores range from 2 to 36, with higher scores indicating higher functioning. Mean change scores will be reported: positive mean change scores indicate increase in sexual functioning over time while negative mean change scores indicate decrease in sexual functioning over time.
Baseline up to 6 weeks
Secondary Outcomes (10)
Change in Self-Reported Partner Sexual Function
Baseline up to 6 weeks
Change in Self-Reported Patient Sexual Distress
Baseline up to 6 weeks
Change in Patients' Self-Reported Relationship Intimacy
Baseline up to 6 weeks
Change in Partners' Self-Reported Relationship Intimacy
Baseline up to 6 weeks
Change in Patients' Self-Reported Relationship Quality
Baseline up to 6 weeks
- +5 more secondary outcomes
Study Arms (2)
Intimacy Enhancement
EXPERIMENTALParticipants attend four sessions (60-75 minutes) consisting of education and skills training to enhance physical and emotional intimacy.
Living Healthy Together
ACTIVE COMPARATORParticipants attend four sessions (60-75 minutes) consisting of information and support across a range of breast cancer-related topics.
Interventions
The IE intervention is grounded in cognitive behavioral couple therapy and sex therapy, and includes education and skills training with a focus on the following major topics: understanding effects of breast cancer on sex and intimacy; goal-setting; communication skills; problem-solving and engaging in activities to build intimacy; identifying and restructuring negative or inflexible thoughts; and planning ahead and preparing for challenges. Participants will be asked to participate in written and behavioral activities at home between sessions to strengthen skills acquisition.
The Living Healthy Together (LHT) intervention focuses on delivering education and support to breast cancer survivors and their partners across a range of topics including social support, sleep and fatigue, stress and stress management, nutrition, and physical activity. Participants will be asked to engage actively with the material and to review readings and intervention material between sessions.
Eligibility Criteria
You may qualify if:
- Patient is female
- Patient age 18 years or older
- Patient has a medically confirmed diagnosis of non-recurrent breast cancer (Stages T1-T4, N0-N1, M0)
- Patient completed active treatment (e.g., chemotherapy, radiation therapy, surgery, immunotherapy) 6 months-5 years ago (current use of endocrine therapy is acceptable)
- Patient is currently in a partnered relationship that could involve sexual activity
- Partner or spouse is 18 years or older
- Patient lives with a romantic partner for at least 6 months
- Patient has a score of at least 3 on Patient Care Monitor Sexual Concerns screening item
You may not qualify if:
- Patient or partner is not able to speak and read English, as stated in medical record, as observed by study team member or in self-report
- Patient or partner ECOG Performance score \> 2 OR medically unable to participate as judged by physician/in medical record or by self-report
- Patient or partner has a hearing impairment
- Patient and partner do not have reliable telephone access
- Patient has overt cognitive dysfunction or psychiatric disturbance such as suicidal ideation or severe mental illness, as observed or judged by the researcher, physician or referring source, or self-report
- Patient past or current history of any cancer other than non-melanoma skin cancer, including prior breast cancer
- Patient is currently participating in couple/marital therapy
- Patient is currently pregnant
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Fox Chase Cancer Centerlead
- National Cancer Institute (NCI)collaborator
Study Sites (1)
Fox Chase Cancer Center
Philadelphia, Pennsylvania, 19111, United States
Related Publications (1)
Reese JB, Zimmaro LA, Lepore SJ, Sorice KA, Handorf E, Daly MB, Schover LR, Kashy D, Westbrook K, Porter LS. Evaluating a couple-based intervention addressing sexual concerns for breast cancer survivors: study protocol for a randomized controlled trial. Trials. 2020 Feb 12;21(1):173. doi: 10.1186/s13063-019-3975-2.
PMID: 32051002DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Jennifer Reese, Associate Professor
- Organization
- Fox Chase Cancer Center
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 24, 2019
First Posted
April 29, 2019
Study Start
May 24, 2019
Primary Completion
April 14, 2023
Study Completion
April 14, 2023
Last Updated
July 11, 2024
Results First Posted
July 11, 2024
Record last verified: 2024-06
Data Sharing
- IPD Sharing
- Will not share